Sponsors

Ready-to-use miRNA assays

Two ready-to-use microRNA (miRNA) assay technologies have been introduced by Qiagen. The two new products, miScript miRNA Mimics and miScript miRNA Inhibitors, are ready-totransfect items for use in gene regulation and cellular pathway analysis.

miScript miRNA Mimics are synthetic RNA oligonucleotides that function like mature endogenous miRNA molecules when transfected in mammalian cells. miScript miRNA Inhibitors are synthetic chemically modified RNA oligonucleotides that inhibit endogenously expressed miRNAs. miRNA Inhibitors effectively lower the levels of endogenous miRNA in cells, thus enabling loss-of-function studies to be performed.

Qiagen supplies miScript miRNA Mimics and miScript miRNA Inhibitors in formats from single tubes to 96- or 384-well plates, and also in different scales (1 nmol and 5 nmol for in vitro use, and 20 nmol for animal studies).

www.qiagen.com

Latest Issues

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026